Meeting
2022 ASCO Annual Meeting
Pathogenic TP53 variant allele frequency across different somatic tissues in two patients with mosaic Li-Fraumeni.
Authors
Tin-Yun Tang
The University of Texas MD Anderson Cancer Center, Houston, TX
Tin-Yun Tang , Duncan Stearns , Alexander Miron , Anna Mitchell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10582)
DOI
10.1200/JCO.2022.40.16_suppl.10582
Abstract #
10582
Poster Bd #
457
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Determining concordance of LFSPRO TP53 germline carrier risk predictions to standard genetic counseling practice.
First Author: Elissa B. Dodd-Eaton
Poster
2021 ASCO Annual Meeting
Identification and characterization of de novo TP53 mutation carriers in Li-Fraumeni syndrome families: A single institution experience.
First Author: Carlos Christian Vera Recio
Poster
2021 ASCO Annual Meeting
Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure.
First Author: Abhay Singh
Poster
2020 ASCO Virtual Scientific Program
Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care.
First Author: Jeffrey N. Weitzel